Literature DB >> 23097262

Stem cells as promising therapeutic options for neurological disorders.

Jongman Yoo1, Han-Soo Kim, Dong-Youn Hwang.   

Abstract

Due to the limitations of pharmacological and other current therapeutic strategies, stem cell therapies have emerged as promising options for treating many incurable neurologic diseases. A variety of stem cells including pluripotent stem cells (i.e., embryonic stem cells and induced pluripotent stem cells) and multipotent adult stem cells (i.e., fetal brain tissue, neural stem cells, and mesenchymal stem cells from various sources) have been explored as therapeutic options for treating many neurologic diseases, and it is becoming obvious that each type of stem cell has pros and cons as a source for cell therapy. Wise selection of stem cells with regard to the nature and status of neurologic dysfunctions is required to achieve optimal therapeutic efficacy. To this aim, the stem cell-mediated therapeutic efforts on four major neurological diseases, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and stroke, will be introduced, and current problems and future directions will be discussed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23097262     DOI: 10.1002/jcb.24427

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  26 in total

Review 1.  Dental pulp stem cells for the study of neurogenetic disorders.

Authors:  A Kaitlyn Victor; Lawrence T Reiter
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  Motor Neuron Transdifferentiation of Neural Stem Cell from Adipose-Derived Stem Cell Characterized by Differential Gene Expression.

Authors:  Marzieh Darvishi; Taki Tiraihi; Seyed A Mesbah-Namin; AliReza Delshad; Taher Taheri
Journal:  Cell Mol Neurobiol       Date:  2016-04-23       Impact factor: 5.046

3.  Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.

Authors:  Nicolas Daviaud; Elisa Garbayo; Laurence Sindji; Alberto Martínez-Serrano; Paul C Schiller; Claudia N Montero-Menei
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

4.  Silk Nanofiber Hydrogels with Tunable Modulus to Regulate Nerve Stem Cell Fate.

Authors:  ShuMeng Bai; WenMin Zhang; Qiang Lu; QuanHong Ma; David L Kaplan; HeSun Zhu
Journal:  J Mater Chem B       Date:  2014-10-14       Impact factor: 6.331

5.  A Quantitative Proteomic Approach Explores the Possible Mechanisms by Which the Small Molecule Stemazole Promotes the Survival of Human Neural Stem Cells.

Authors:  Mingzhu Chen; Yizi Zhu; Huajun Li; Yubo Zhang; Mei Han
Journal:  Brain Sci       Date:  2022-05-25

6.  Sizes and Sufficient Quantities of MSC Microspheres for Intrathecal Injection to Modulate Inflammation in Spinal Cord Injury.

Authors:  Suneel Kumar; Joanne Babiarz; Sayantani Basak; Jae Hwan Kim; Jeffrey Barminko; Andrea Gray; Parry Mendapara; Rene Schloss; Martin L Yarmush; Martin Grumet
Journal:  Nano Life       Date:  2015-12

7.  3D bioprinting: A new insight into the therapeutic strategy of neural tissue regeneration.

Authors:  Fu-Yu Hsieh; Shan-hui Hsu
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

8.  Erythropoietin produced by genetic-modified NIH/3T3 fibroblasts enhances the survival of degenerating neurons.

Authors:  Yi-Chin Li; Shiu-Jau Chen; Chung-Liang Chien
Journal:  Brain Behav       Date:  2015-06-03       Impact factor: 2.708

9.  The human gastrointestinal tract, a potential autologous neural stem cell source.

Authors:  Cornelia Irene Hagl; Sabine Heumüller-Klug; Elvira Wink; Lucas Wessel; Karl-Herbert Schäfer
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  MSCs‑derived exosomes attenuate ischemia-reperfusion brain injury and inhibit microglia apoptosis might via exosomal miR-26a-5p mediated suppression of CDK6.

Authors:  Chang Cheng; Xiuying Chen; Yuhan Wang; Wenchao Cheng; Xuzheng Zuo; Weiju Tang; Wen Huang
Journal:  Mol Med       Date:  2021-07-02       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.